Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
Clinical trial NCT05358080 · UNKNOWN
Trial details
- NCT number
- NCT05358080
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2024-12-16
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.